Insider Transactions in Q2 2022 at Re Shape Lifesciences Inc. (RSLS)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2022
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,478
-1.22%
|
$0
$0.96 P/Share
|
|
Jun 01
2022
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
11,309
-0.7%
|
$0
$0.96 P/Share
|
|
May 31
2022
|
Thomas Stankovich Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+0.69%
|
$0
$0.91 P/Share
|
|
May 05
2022
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,529
-1.29%
|
$0
$0.77 P/Share
|
|
May 05
2022
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
11,417
-1.39%
|
$0
$0.77 P/Share
|
|
Apr 01
2022
|
Barton P. Bandy President and CEO |
SELL
Open market or private sale
|
Direct |
11,063
-1.33%
|
$11,063
$1.13 P/Share
|
|
Apr 01
2022
|
Thomas Stankovich Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,038
-1.42%
|
$5,038
$1.13 P/Share
|